UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by PUREfi Wealth LLC

PUREfi Wealth LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 30.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 692 shares of the healthcare conglomerate’s stock after selling 305 shares during the quarter. PUREfi Wealth LLC’s holdings in UnitedHealth Group were worth $363,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of UNH. Kingswood Wealth Advisors LLC lifted its holdings in shares of UnitedHealth Group by 33.5% during the first quarter. Kingswood Wealth Advisors LLC now owns 13,526 shares of the healthcare conglomerate’s stock worth $7,080,000 after purchasing an additional 3,394 shares during the period. Accelerate Investment Advisors LLC lifted its position in UnitedHealth Group by 10.3% in the first quarter. Accelerate Investment Advisors LLC now owns 892 shares of the healthcare conglomerate’s stock valued at $467,000 after purchasing an additional 83 shares during the period. Puzo Michael J boosted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. Puzo Michael J now owns 15,983 shares of the healthcare conglomerate’s stock valued at $8,371,000 after buying an additional 150 shares in the last quarter. Cornerstone Wealth Management LLC boosted its position in shares of UnitedHealth Group by 3.0% during the 1st quarter. Cornerstone Wealth Management LLC now owns 1,889 shares of the healthcare conglomerate’s stock worth $989,000 after purchasing an additional 55 shares in the last quarter. Finally, Shepherd Financial Partners LLC grew its position in UnitedHealth Group by 0.6% during the first quarter. Shepherd Financial Partners LLC now owns 5,811 shares of the healthcare conglomerate’s stock worth $3,043,000 after buying an additional 35 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on UNH shares. Royal Bank Of Canada reduced their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a report on Tuesday, June 3rd. JPMorgan Chase & Co. reduced their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a research note on Thursday, May 15th. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $426.52.

UnitedHealth Group Stock Up 0.5%

Shares of UnitedHealth Group stock opened at $309.14 on Wednesday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a fifty day moving average price of $376.32 and a 200 day moving average price of $469.08. The stock has a market cap of $280.43 billion, a price-to-earnings ratio of 12.95, a price-to-earnings-growth ratio of 1.44 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period in the previous year, the business posted $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. UnitedHealth Group’s payout ratio is presently 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John F. Rex acquired 17,175 shares of UnitedHealth Group stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.